NCT04419558 Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE3
NCT04419506 A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT04396756 Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT04362644 Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis Status RECRUITING Phase PHASE1
NCT04326036 Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection Status UNKNOWN Phase EARLY_PHASE1
NCT04318704 Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough Status COMPLETED Phase PHASE2
NCT04316780 Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes Status COMPLETED Phase N/A
NCT04312594 Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT04300920 Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial Status COMPLETED Phase PHASE3
NCT04257630 Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD Status COMPLETED Phase N/A
NCT04244825 Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF Status WITHDRAWN Phase PHASE2
NCT04233814 Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT04197791 Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT04187079 Immunopathologic Profiles and Blood Biomarkers in Patients With IPF Status COMPLETED Phase N/A